MannKind

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$3.51-$7.63
Market Cap
$1.1B
Shares Short
25M

Financials

See more
Revenue (12 Mos)
$297.5M
Revenue Growth (YoY)
18.2%
Gross Profit (12 Mos)
$222M
Diluted EPS
$0.10

News

See more

Yahoo Finance • 15 hours ago

Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT

Yahoo Finance • 11 days ago

MannKind Corp stock hits 52-week low at $3.63

Yahoo Finance • 19 days ago

MannKind (MNKD) Presents Pediatric Insulin Trial Data

Yahoo Finance • last month

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23

About

CEO
Dr. Michael E. Castagna Pharm.D.
Address
1 Casper Street, Danbury, CT, United States, 06810
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
403